SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Albright AL, Packer RJ, Zimmermann R, et al. Magnetic resonance scans should replace biopsies for the diagnosis of diffuse brainstem gliomas: a report of the Children's Cancer Group. Neurosurgery. 1993; 33: 10261029.
  • 2
    Kaplan AM, Albright AL, Zimmerman RA, et al. Brainstem gliomas in children. A Children's Cancer Group review of 119 cases. Pediatr Neurosurg. 1999; 24: 185192.
  • 3
    Guillamo JS, Doz F, Delattre JY. Brain stem gliomas. Curr Opin Neurol. 2001; 14: 711715.
  • 4
    Mandell L, Kadota R, Freeman C, et al. There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a Pediatric Oncology Group phase III trial comparing conventional vs. hyperfractionated radiotherapy. Int J Radiat Oncol Biol Phys. 1999; 43: 959964.
  • 5
    Doz F, Neuenschwander S, Bouffet E, et al. Carboplatin before and during radiation therapy for the treatment of malignant brain stem tumours: a study by the Societe Francaise d'Oncologie Pediatrique. Eur J Cancer. 2002; 38: 815819.
  • 6
    Lashford LS, Thiesse P, Jouvet A, et al. Temozolomide in malignant gliomas of childhood: a United Kingdom Children's Cancer Study Group and French Society for Pediatric Oncology Intergroup Study. J Clin Oncol. 2002; 20: 46844691.
  • 7
    Broniscer A, Iacono L, Chintagumpala M, et al. Role of temozolomide after radiotherapy for newly diagnosed diffuse brainstem glioma in children: results of a multiinstitutional study (SJHG-98). Cancer. 2005; 103: 133139.
  • 8
    Gentet JC, Frappaz D, Pautard B, et al. Procarbazine in children with malignant brainstem glioma: a SFOP phase II study [abstract P-37]. Med Pediatr Oncol. 1999; 33: 205.
  • 9
    Freeman CR, Kepner J, Kun LE, et al. A detrimental effect of a combined chemotherapy-radiotherapy approach in children with diffuse intrinsic brain stem gliomas? Int J Radiat Oncol Biol Phys. 2000; 47: 561564.
  • 10
    Bouffet E, Raquin M, Doz F, et al. Radiotherapy followed by high dose busulfan and thiotepa: a prospective assessment of high dose chemotherapy in children with diffuse pontine gliomas. Cancer. 2000; 88: 685692.
  • 11
    Dunkel IJ, Garvin JH Jr., Goldman S, et al. High dose chemotherapy with autologous bone marrow rescue for children with diffuse pontine brain stem tumors. Children's Cancer Group. J Neurooncol. 1998; 37: 6773.
  • 12
    Chastagner P, Kozin SV, Taghian A. Topotecan selectively enhances the radioresponse of human small-cell lung carcinoma and glioblastoma multiforme xenografts in nude mice. Int J Radiat Oncol Biol Phys. 2001; 50: 777782.
  • 13
    Chastagner P, Pinel S, Merlin JL, et al. Influence of overall treatment time of topotecan and radiotherapy administered alone or in combination in two xenografted human glioblastoma multiforme. Proc Am Soc Clin Oncol. 2001; 20: 60a.
  • 14
    Kingsbury WD, Boehm JC, Jakas DR, et al. Synthesis of water-soluble (aminoalkyl)camptothecin analogues: inhibition of topoisomerase I and antitumor activity. J Med Chem. 1991; 34: 98107.
  • 15
    Marchesini R, Colombo A, Caserini C, et al. Interaction of ionizing radiation with topotecan in two human tumor cell lines. Int J Cancer. 1996; 66: 342346.
  • 16
    Lamond JP, Mehta MP, Boothman DA. The potential of topoisomerase l inhibitors in the treatment of CNS malignancies: report of a synergistic effect between topotecan and radiation. J Neurooncol. 1996; 30: 16.
  • 17
    Needle MN, Mehlta M, Krailo M, et al. Phase I study of topotecan as a radiosensitizer prior to daily involved field irradiation in children with intrinsic pontin glioma [abstract]. Proc Am Soc Clin Oncol. 1999: 18: 558a.
  • 18
    Bellissant E, Benichou J, Chastang C. Application of the triangular test to phase II cancer clinical trials. Stat Med. 1990; 9: 907917.
  • 19
    Chastagner P, Bouffet E, Grill J, Kalifa C. What have we learnt from previous phase II trials to help in the management of childhood tumours? Eur J Cancer. 2001; 37: 19811993.
  • 20
    Broniscer A, Gajjar A. Supratentorial high-grade astrocytoma and diffuse pontine brainstem glioma: two challenges for the pediatric oncologist. Oncologist 2004; 9: 197206.
  • 21
    Benesch M, Lackner H, Moser A, et al. Outcome and long-term side effects after synchronous radiochemotherapy for childhood brain stem gliomas. Pediatr Neurosurg. 2001; 35: 173180.
  • 22
    Blaney SM, Cole DE, Balis FM, Godwin K, Poplack DG. Plasma and cerebrospinal fluid pharmacokinetic study of topotecan in nonhuman primates. Cancer Res. 1993; 53: 725727.
  • 23
    Chen AY, Choy H, Rothenbery ML. DNA topoisomerase I-targeting drugs as radiation sensitizers. Oncology (Huntingt). 1990; 13 (Suppl): 3946.
  • 24
    Allen J, Siffert J, Donahue B, et al. A phase I/II study of carboplatin combined with hyperfractionated radiotherapy for brainstem gliomas. Cancer. 1999; 86: 10641069.
  • 25
    Broniscer A, Leite CC, Lanchote VL, et al. Radiation therapy and high-dose tamoxifen in the treatment of patients with diffuse brainstem gliomas: results of a Brazilian cooperative study. Brainstem Glioma Cooperative Group. J Clin Oncol. 2000; 18: 12461253.
  • 26
    Wolff JE, Westphal S, Molenkamp G, et al. Treatment of paediatric pontine glioma with oral trophosphamide and etoposide. Br J Cancer. 2002; 21: 945949.
  • 27
    Marcus KJ, Dutton SC, Barnes P, et al. A phase I trial of etanidazole and hyperfractionated radiotherapy in children with diffuse brainstem glioma. Int J Radiat Oncol Biol Phys. 2003; 55: 11821185.
  • 28
    Sanghavi SN, Needle MN, Boyett JM, et al. A phase I study of topotecan as radiosensitizer for brainstem gliomas of childhood: first report of the Children's Cancer Group-0952. Neuro-oncol. 2003; 5: 813.
  • 29
    Grabenbauer GG, Anders K, Fietkau RJ, et al. Prolonged infusional topotecan and accelerated hyperfractionated 3d-conformal radiation in patients with newly diagnosed glioblastoma-a phase I study. J Neurooncol. 2002; 60: 269275.
  • 30
    Lesimple T, Hassel MB, Gedouin D, et al. Phase I study of topotecan in combination with concurrent radiotherapy in adults with glioblastoma. J Neurooncol. 2003; 65: 141148.
  • 31
    Fisher B, Won M, MacDonald D, et al. Phase II study of topotecan plus cranial radiation for glioblastoma multiforme: results of Radiation Therapy Oncology Group 9513. Int J Radiat Oncol Biol Phys. 2002; 53: 980986.
  • 32
    Packer RJ, Prados M, Phillips P, et al. Treatment of children with newly diagnosed brain stem gliomas with intravenous recombinant beta-interferon and hyperfractionated radiation therapy: a childrens cancer group phase I/II study. Cancer. 1996; 77: 21502156.
  • 33
    Jennings MT, Sposto R, Boyett JN, et al. Preradiation chemotherapy in primary high-risk brainstem tumors: phase II study CCG-9941 of the Children's Cancer Group. J Clin Oncol. 2002; 20: 36313637.